Autoimmmune dx Flashcards

1
Q

Define Systemic Lupus Erythematosis

A
  1. Chronic inflammatory autoimmune disorder that affects connective tissue
  2. Characterized by autoantibodies to nuclear antigens
  3. Can affect multiple organ systems
  4. Commonly affects women of child bearing age
  5. Signs and sx’s vary
    A. Severity variable
    Mild to life threatening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the types of SLE? Who is affected with each type?

A
  1. Discoid Lupus - targets the skin
    A> Severe inflammation, scarring and rashes on the face, scalp and ears
    B> Absence of systemic disease, or may occur in assoc. w/SLE
    C. 16.7% progress to SLE w/in 3 yr of Dx
  2. Systemic Lupus Erythematosus - affects organs and joints
  3. Sub-acute cutaneous lupus – assoc. w/skin lesions
  4. Drug-induced lupus - due to drug reaction
  5. Neonatal lupus - affects newborns
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the rf fro SLE?

A
  1. Genetics
  2. F > M
  3. Certain medications
    A. Procainamide
    B. Hydralazine
    C. Isoniazid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the pathophys of SLE?

A
  1. Immune system produces anti-nuclear antibodies
  2. Ag-Ab complexes form
  3. Immune complexes become trapped in capillaries of visceral structures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the sxs of SLE?

A
1. Joint sx’s
A. Symmetrical arthritis 
-Earliest manifestation of disease (peripheral joints)
2. Discoid rash
A. Raised erythematous patches w/plaques & scales
3. Malar rash
A. Characteristic “butterfly rash”
B. Present in < 50% pts
4. Oral/nasopharyngeal ulcers 
5. Raynaud’s Phenomenon
6. Photosensitivity
A. Leg ulcerations
7. Neurologic sx’s
A. Seizures, psychosis
8. Cardiopulmonary (Serositis) sx’s
A. Pericarditis, endocarditis, murmurs, pleuritis
9. Hematologic manifestations
A. Hemolytic anemia, thrombocytopenia, leukopenia, lymphopenia
B. Petechiae, pallor
10. Renal manifestations
A. Proteinuria, casts
11. Other
A. Fever, conjunctivitis, dry eyes, dry mouth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What dx studies are used in SLE?

A
Combination of blood & urine tests, signs & sx’s, & exam findings leads to Dx
 ≥ 4 (+) signs/sx’s
1. ESR
2. ANA: screening test
3. Anti–Double Stranded DNA Ab
4. Anti-Smith(Sm) Ab
5. Serum complement
6. CBC w/ diff
7. BUN/Cr, UA
8. CXR
9. Echo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the ESR results in SLE?

A

Usually elevated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the ANA results in SLE?

A
  1. Indicates a stimulated immune system
  2. (+) in 95-100% pts
  3. Not specific
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the Anti-double stranded DNA Ab results in SLE?

A
  1. (+) in 60% pts

2. Used as markers in disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the Anti-Smith (Sm) Ab results in SLE?

A

(+) in 20% pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the serum complement results in SLE?

A

decreased in 60% pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is a CBC w/ diff used in SLE?

A

Evaluate for anemia, thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is a BUN/Cr, UA used in SLE?

A

Evaluate renal function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why is a CXR used in SLE?

A

R/O effusions or inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is an ECHo used in SLE?

A

Valve disease (+) in 18% pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How are the arthralgias and mild serositis in SLE treated?

A
  1. NSAIDs
  2. Hydroxychloroquine sulfate (Plaquenil)
    A. Antimalarial -> inhibits phospholipid metabolism & plt aggregation; suppresses immune system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How are the skin symptoms in SLE treated?

A
  1. Antimalarial
  2. Topical corticosteroids, intradermal steroids (discoid)
  3. Sunscreen
  4. Immunosuppressive drugs
    A. Methotrexate (Trexall)
    B. Azathioprine (Imuran)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How is nephritis in SLE treated?

A
1. Corticosteroids (pulse dose)
       \+
2. Cyclophosphamide (Cytoxan) IV monthly
           THEN 
3. Maintain on immunosuppressant
A. Mycophenolate mofetil (CellCept) OR
B. Azathioprine (Imuran) OR
C. Rituximab (Rituxan)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How is the Rapidly progressive renal failure or systemic vasculitis in SLE treated?

A

Plasmapheresis + Immunosuppressant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How are the CNS sxs of SLE treated?

A

Corticosteroids, anticonvulsants, antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How is anemia and thrombocytopenia in SLE treated?

A

Corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the px for SLE?

A
  1. 10 year survival rate > 85%
    2, Relapsing and remitting course
  2. In some cases, SLE is virulent, leading to severe impairment of lungs, heart, kidneys, brain
  3. 5X higher risk of MI
  4. Increased risk of lymphoma, lung CA and cervical CA
  5. Avascular necrosis of hips/knees
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the inflammatory myopathies?

A
  1. Polymyositis

2. Dermatomyositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Define polymyositis

A
1. Idiopathic Dz of striated muscle
A. Muscle weakness 
B. Inflammation  
C. Muscle fiber breakdown
2. Affects proximal limbs, neck & pharynx
3. Can also affect skin
Dermatomyositis
A. 25% of these pts will have malignancy
4. Other organ systems affected: Joints, lungs, heart, GI tract
5. Etiology unknown
6. F > M
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the sxs of polymyositis/dermatomyositis?

A
1. Insidious onset
A. Weeks to months
2. Painless symmetrical proximal muscle weakness
A. Neck, shoulders, pelvic girdle
3. Dysphagia & dysphonia
4. Sensation & reflexes preserved
5. Esophageal dysmotility in dermatomyositis
6. Muscle atrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the sxs of dermatomyositis?

A
  1. Erythematous rash on face
  2. Photosensitivity
  3. Nail changes
    A. Cracking, thickening, periungual telangiectasia
  4. Shawl sign
    A. Erythema over neck, shoulders, upper chest & back
  5. Heliotrope rash
    A. Periorbital edema with purplish rash of eyelids
  6. Gottron’s papules
    A. Violaceous (violet) papules over dorsum of PIP & MCP joints, elbows, knees
  7. Mechanic’s hand
    A. Fissured, hyperpigmented, scaly skin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is the morbidity and mortality of dermatomyositis/polymyositis?

A
  1. Resp failure 2° to pulmonary fibrosis
  2. Cardiac conduction abn w/dermatomyositis
  3. Systemic autoimmune Dz
    A. PM>DM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the dx studies for polymyositis/dermatomyositis?

A
  1. Lytes, TSH, Ca, Mg
  2. CK-MM
  3. muscle bx
  4. CXR
  5. Barium Swallow
  6. EKG
  7. EMG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the CK-MM results in polymyositis/dermatomyositis?

A
  1. Up to 50x normal
  2. ↑ due to muscle inflammation
  3. ↑ ALT, AST, ANA, Alk Phos, LDH
  4. +/- ↑RF
  5. ↑ anti-Jo-1 Ab if interstitial lung Dz
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is the confirmatory test for polymyositis/dermatomyositis?

A

Muscle bx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Why are lytes checked in polymyositis/dermatomyositis?

A

R/O other causes of weakness (WNL)

32
Q

How is polymyositis/dermatomyositis treated?

A
  1. High dose steroids (Acute sx’s)
  2. IV IgG, IV Cytoxan
    A. If Prednisone not effective or sx’s return s tapering
  3. Hydroxychloroquine (Plaquenil) for rash
  4. Sunscreen
  5. PT
  6. OT
  7. Speech Therapy
33
Q

define Polymyalgia Rheumatica

A
  1. Syndrome characterized by pain & stiffness in neck, shoulders, torso & pelvic girdle
  2. Accompanied by constitutional sx’s
    A. Fever, fatigue, weight loss, depression: Not at onset, but may develop over time
  3. ≈ 33% cases co-exist with Giant cell arteritis (temporal arteritis)
    A. H/A
34
Q

What is the demographic group asst with polymyalgia rheumatica?

A

F > M

Age > 50 yrs

35
Q

What are the sxs of polymyalgia rheumatica?

A
1. Symmetric pain & stiffness > 1 mo
A. Neck, shoulders, torso, & pelvic girdle
B. Severe after rest and in AM
2. Arthralgias usually symmetric
3. Normal muscle strength
4. Fever, malaise, wt. loss
5. Increasing sx’s over weeks or months
6. Depression develops
36
Q

What dx studies may be used for polymyalgia rheumatica?

A
  1. Clinical Dx
  2. Diagnostics
    A. CBC
    -Mild anemia
    B. ESR
    -Elevated ESR ≥ 40 mm/hr
    -20% have normal ESR
37
Q

How is polymyalgia rheumatica treated?

A
  1. Mild case-NSAIDs
  2. Prednisone 10-20 mg qd up to 2 yrs
  3. Sx relief w/in 48-72 hr confirms Dx, otherwise look for other cause
  4. Taper Tx based on clinical exam and repeat ESR’s
  5. Get baseline dexascan in females
38
Q

Define scleroderma/Systemic Sclerosis

A
  1. Connective tissue disorder

2. Thickening & fibrosis of skin & internal organs

39
Q

What are the demographic groups asst. with scleroderma?

A
  1. Unknown etiology
  2. Genetic & environmental component
  3. F > M
  4. Presents between 20-50 yr
40
Q

What are the 2 types of scleroderma?

A
  1. Limited
    A. Hardening of skin limited to hands and face
  2. Diffuse
    A. Involves hands, face, trunk, proximal extremities
41
Q

What is the pathophys of scleroderma?

A

Increased collagen synthesis(causes sclerosis), damage to small blood vessels, activation ofT lymphocytes& production of alteredconnective tissues

42
Q

What is the mneumonic for scleroderma sxs?

A

CREST

  1. Clacinosis: calcium deposits in the skin
  2. Raynaud’s: spasm of blood vessels in response to cold or stress
  3. Esophageal dysfunction: acid reflux and decrease and in mobility of esophagus
  4. Scleradactyly: thickening and tightening of the skin of the fingers and hands
  5. Telanglectasias: dilation of capillaries causing red marks on surface of the skin
43
Q

What are the sxs of Scleroderma?

A
  1. Raynaud’s phenomenon usually initial manifestation
  2. Skin (hands, then face)
    A. Shiny, taut, loss of creases & hair
    B. Limited movement
    C. Pigment color change
    D. Atrophy in late stages
  3. MSK
    A. Symmetric arthritis
    B. Myopathy
  4. GI
    A. Dysmotility
  5. Pulmonary
    Fibrosis
    A. Pulm HTN
  6. CV
    A. Fibrosis→ cardiomyopathy→ CHF
  7. Renal
    A. Malignant HTN
    B. Renal failure
  8. Other
    A. Hypothyroidism
    B. ED
    C. Sjogren’s Syndrome
    D. Entrapment neuropathies
    E. CREST syndrome
44
Q

How is scleroderma diagnosed? What dx studies are used?

A
  1. Generally Dx of exclusion
  2. ANA
  3. RF
  4. CBC
  5. AutoAb against platelet-derived growth factor (PDGF)
  6. Joint x-rays prn
  7. pulmonary: CXR, Chest CT, Bronchoscopy w/ Bx
  8. CV: Echo, EKG, holter monitor, catheterization
  9. GI studies: Barium swallow, esophageal manometry, endoscopy
45
Q

What are the ANA results in scleroderma?

A

(+) in 90% cases

46
Q

What are the RF results in scleroderma?

A
  1. 30% (+)
  2. (+) Anticentromere Ab
  3. Good prognosis if (+)
47
Q

Why is a CBC checked in scleroderma?

A
  1. Mild anemia
    A. Microangiopathic hemolytic anemia
    -Mechanical damage to RBC’s from diseased small vessels
48
Q

What is the hallmark dx finding for scleroderma?

A

AutoAb against platelet-derived growth factor (PDGF)

49
Q

How is scleroderma treated?

A
  1. Symptomatic and supportive
  2. Organ specific (some examples):
    A. Raynaud’s: CCB or periph alpha blockers
    B. Esophageal reflux: PPI, H2 blockers
    C. Arthralgia: NSAIDs
    D. Pulm HTN: O2, lung transplant, Cytoxan if interstitial lung Dz
    E. Renal: ACEI, Dialysis, Transplant
50
Q

What is the px for scleroderma?

A
  1. 5 yr survival rate 85%
  2. 10 yr survival rate < 70%
  3. Leading causes of mortality
    A. Pulmonary HTN
    B. Pulmonary fibrosis
    C. Scleroderma renal crisis
51
Q

Define Sjogren’s syndrome

A
1. Autoimmune disease that destroys salivary and lacrimal glands
A. Primary
B. Secondary
-Assoc with other disorders
RA, SLE, Scleroderma
C. Increased incidence of lymphoma
52
Q

What are the demographics for Sjogren’s syndrome?

A
  1. F > M

2. Average age @ Dx 50 yrs

53
Q

What are the sxs of sjogren’s syndrome?

A
1. Xerostomia
A. Dry mouth
B. ↓ saliva production
2. Xerophthalmia
A. Dry eyes or keratoconjuctivitis
B. ↓ tear production
3. Enlarged parotid gland
A. Due to lymphocytic infiltration
4. Dry, gritty or burning sensation in the eyes
5. Dry mouth
6. Difficulty talking, chewing or swallowing
7. Sore or cracked tongue
8. Dry or burning throat
9. Dry or peeling lips
10. Change in taste or smell
11. Increased dental decay
12. Joint pain
13. Vaginal and skin dryness
14. Digestive problems
15. Dry nose
16. Fatigue
54
Q

What dx studies and results are used in sjogren’s syndrome?

A
1. RF
A. (+) in 70% pts
2. ANA
A. (+) in 95% pts
3. ESR
A. Elevated in 70% pts
4. Anti-SSA & anti-SSB Ab
A. (+) in 65% pts
5. Schirmer’s test
6. LFT’s
A. May be elevated
7. CBC
A. Normochromic normocytic anemia
8. Definitive Dx
A. Salivary gland Bx
55
Q

What is schirmer’s test?

A
  1. Evaluates tear secretions produced by lacrimal gland

2. Filter paper placed under lid → saturation (+ if < 8mm wetting/5 min)

56
Q

What is the confirmatory test for sjogren’s syndrome?

A

Salivary gland bx

57
Q

How is Sjogren’s syndrome treated?

A
1. Symptomatic
A. Fluid replacement
B. Good oral hygiene 
C. Keep mucosal surfaces moist
-Artificial tears, Cyclosporine Ophth. emulsion (Restasis)
-Chew gum
-Cholinergic receptor stimulators 
-Pilocarpine (Salagen) 5 mg po qid 
-Cevimaline (Evoxac) 30 mg po tid
58
Q

Define fibromyalgia

A
  1. Chronic aching pain & stiffness, frequently involving the entire body
    A. Prominence of pain around neck, shoulders, low back & hips
  2. Can occur independently or with other rheumatologic diseases
59
Q

What are the demographics for fibromyalgia?

A

F > M

Age group 20-50 yrs

60
Q

What is the pathophys of fibromyalgia?

A

Abnormal sensory processing of pain in CNS

61
Q

What are the sxs of fibromyalgia?

A
  1. Non-articular musculoskeletal aches & pains
  2. Fatigue
  3. Sleep disturbance
  4. Multiple trigger points of pain
    A. Trapezius muscle
    B. Medial fat pad of knee
    C. Lateral epicondyle elbow
62
Q

How is fibromyalgia diagnosed?

A
  1. No routine laboratory markers
  2. Dx of exclusion, commonly ordered labs:
    A. ESR or CRP – R/O RA, SLE, PMR
    B. FT4, TSH – R/O hypothyroidism
    C. CBC – R/O anemia
63
Q

What are the goals of treatment for fibromyalgia?

A

↓ pain, improve muscle & joint function, avoid triggers that exacerbate sx’s

64
Q

What are the non-medical treatment options for fibromyalgia?

A
  1. Patient education
  2. Stress reduction
  3. Sleep hygiene
  4. Treat psychological problems
    A. Behavioral counseling
  5. Exercise program
  6. Other
    A. Trigger pt. inj., acupuncture, Chiropractic, massage, PT
65
Q

What are the medical treatment options for fibromyalgia?

A
  1. OTC’s
  2. Duloxetine (Cymbalta)
  3. Milnacipran (Savella)
  4. Gabapentin (Neurontin)
  5. Pregabalin (Lyrica)
  6. Amitriptyline (Elavil)
  7. Tramadol (Ultram)
  8. Muscle relaxers
  9. Raloxifene (Evista)
    A. qod (selective estrogen receptor modulator)
    10 Propranolol (Inderal
66
Q

Define Granulomatosis with Polyangiitis (GPA)/Wegener’s granulomatosis

A
  1. Systemic disorder leading to damage to lungs & kidneys that can be fatal
  2. Vasculitic syndrome featuring attack by circulating Ab termed ANCAs (antineutrophil cytoplasmic antibodies) against small and medium-size blood vessels
67
Q

What causes GPA/Wegener’s granulomatosis?

A
  1. Rare in Japan and African Americans
  2. Unknown cause
    Microbes (bacteria and viruses)?
    Genetic predisposition?
68
Q

What is the pathophys of GPA/Wegener’s granulomatosis?

A
  1. Inflammation with granuloma formation
  2. Anti-neutrophil cytoplasmic antibodies (ANCAs) are responsible for the inflammation
  3. Suspected if unexplained symptoms for a long period of time
69
Q

What are the sxs of GPA/Wegener’s granulomatosis?

A
  1. Rhinitis
    A. Usually 1st sign in most people
  2. Rapidly progressive glomerulonephritis → chronic kidney failure
  3. EENT disorders
  4. Lungs
    A. Pulmonary nodules (“coin lesions”), infiltrates, hemoptysis
  5. Arthritis
    A. Pain or swelling (60%), commonly misdiagnosed as RA
  6. Skin
    A. Nodules on the elbow, purpura (cutaneous vasculitis)
  7. Nervous system
    A. Sensory neuropathy (10%)
    *Heart, GI tract, brain rarely affected
70
Q

What are the EENT disorders asst with GPA/Wegener’s granulomatosis?

A
  1. Nose: pain, stuffiness, epistaxis, rhinitis, crusting, saddle-nose deformity 2° perforated septum
  2. Ears:Hearing loss
  3. Oral cavity:gingivitis, bone destruction with loosening of teeth, oral ulcerations
  4. Eyes: pseudotumours, scleritis, conjunctivitis, uveitis, episcleritis
  5. Trachea: subglottal stenosis
71
Q

What are the dx studies for GPA/Wegener’s granulomatosis?

A
  1. +/- ANCAs
    A. Not always diagnostic
  2. If renal failure or cutaneous vasculitis, renal Bx
  3. Rarely lung Bx
72
Q

What are the lung bx results in GPA/Wegener’s granulomatosis?

A
  1. (+) Bx result (50% specificity)
    A. Leukocytoclastic vasculitis w/necrotic changes and granulomatous inflammation (clumps of typically arranged white blood cells)
    B. Necrotizing granulomas are hallmark of Dz
73
Q

How is GPA/Wegener’s granulomatosis diagnosed?

A
1. 2 or > (+) criteria = high sensitivity of Dx
A. Nasal or oral inflammation
B. Abn. CXR 
-nodules, infiltrates or cavities
C. Urine sediment 
-Microscopic hematuria or red cell casts
D. Biopsy 
-Granulomatous inflammation
74
Q

How is GPA/Wegener’s granulomatosis treated?

A
  1. Induce remission
    A. Cyclophosphamide (Cytoxan) OR Rituximab (Rituxan)
    +
    B. High dose corticosteroids
  2. Less toxic immunosuppressants used to prevent relapse
    A. Methotrexate (Trexall)
75
Q

What is the prognosis for GPA/Wegener’s granulomatosis?

A
  1. 5-year survival > 80%
  2. Long-term complications are common (86%)
    A. Chronic renal failure
    B. Hearing loss and deafness